Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

导出原文传递

翻译打印收藏纠错

作者： Cefalu, William T. ^[1] ; Leiter, Lawrence A. ^[2] ; de Bruin, Tjerk W. A. ^[3] ; Gause-Nilsson, Ingrid ^[4] ; Sugg, Jennifer ; Parikh, Shamik J.

作者单位： Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada ^[1] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA ^[2] AstraZeneca, Global Med Dev, Molndal, Sweden ^[3] AstraZeneca, Global Med Dev, Gaithersburg, MD USA ^[4]

发布时间 2018-09-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Diabetes care

2015年38卷7期

1218-1227页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

Diabetes care

相似文献

Diabetes care

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

Diabetes care

相似文献

Diabetes care

相关期刊

检索历史清除